NeuroMetrix, Inc.
DelistedCIK 1289850fmd_17M5Z91PVZHM6VVN8A4GTAAN11Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2009 to Dec 31, 2024, 60 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 7 | 12 | 17 | 16 | 9 | 7 | 8 | 8 | 6 | 3 |
| Cost of revenue | 4 | 7 | 10 | 9 | 7 | 2 | 2 | 3 | 2 | 1 |
| Gross profit | 3 | 5 | 7 | 7 | 2 | 5 | 6 | 6 | 4 | 2 |
| Research and development | 4 | 4 | 3 | 5 | 3 | 2 | 3 | 3 | 3 | 2 |
| Selling, general and administrative | 13 | 16 | 16 | 15 | 11 | 5 | 6 | 7 | 8 | 9 |
| Total operating expenses | 17 | 20 | 20 | 20 | 14 | 7 | 8 | 10 | 11 | 10 |
| Operating income | (13) | (15) | (13) | (12) | (12) | (2) | (2) | (5) | (7) | (9) |
| Interest and investment income | 0 | 0 | 0 | – | – | – | – | 0 | 0 | – |
| Other non-operating income (expense) | – | – | – | – | 8 | 0 | – | 0 | 1 | 1 |
| Income before taxes | – | – | – | – | – | – | – | – | – | – |
| Income tax expense | – | – | 0 | 0 | 0 | – | – | – | – | – |
| Net income from continuing operations | – | – | – | – | – | – | – | – | – | – |
| Net income | (9) | (15) | (13) | 0 | (4) | (2) | (2) | (4) | (7) | (8) |
| Net income to common shareholders | (21) | (35) | (20) | 0 | (4) | (2) | (2) | (4) | (7) | (8) |